Past studies using RUSH reporters to examine TGN exit have relied on surrogate markers, such as secretogranin II and neuropeptide Y (NPY), to investigate soluble proteins trafficking dynamics in insulinoma cells29; however, our study provides the first example of this technique with proinsulin in primary β-cells. The gene discussed is NPY; the disease is pancreatic insulinoma.